DS-1093

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameDS-1093
Drug Alias NameDS-1093DS-1093a
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHypoxia-inducible factor prolyl hydroxylase inhibitors
TargetsHypoxia-inducible factor prolyl hydroxylase
Therapy Area/IndicationsAnemiaRenal Insufficiency, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaHungaryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo IncDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsAnemiaRenal Insufficiency, Chronic

Other Information

ATC CodeN/A
Related LinksN/A